Chapter title |
Methods for Derivation of Multipotent Neural Crest Cells Derived from Human Pluripotent Stem Cells.
|
---|---|
Chapter number | 234 |
Book title |
Embryonic Stem Cell Protocols
|
Published in |
Methods in molecular biology, May 2015
|
DOI | 10.1007/7651_2015_234 |
Pubmed ID | |
Book ISBNs |
978-1-4939-2953-5, 978-1-4939-2954-2
|
Authors |
Avery, John, Dalton, Stephen, John Avery, Stephen Dalton |
Abstract |
Multipotent, neural crest cells (NCCs) produce a wide range of cell types during embryonic development. This includes melanocytes, peripheral neurons, smooth muscle cells, osteocytes, chondrocytes, and adipocytes. The protocol described here allows for highly efficient differentiation of human pluripotent stem cells to a neural crest fate within 15 days. This is accomplished under feeder-free conditions, using chemically defined medium supplemented with two small molecule inhibitors that block glycogen synthase kinase 3 (GSK3) and bone morphogenic protein (BMP) signaling. This technology is well suited as a platform to understand in greater detail the pathogenesis of human disease associated with impaired neural crest development/migration. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | 3% |
Unknown | 31 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 6 | 19% |
Researcher | 5 | 16% |
Student > Master | 4 | 13% |
Student > Bachelor | 3 | 9% |
Professor > Associate Professor | 3 | 9% |
Other | 4 | 13% |
Unknown | 7 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 12 | 38% |
Agricultural and Biological Sciences | 5 | 16% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Computer Science | 1 | 3% |
Earth and Planetary Sciences | 1 | 3% |
Other | 4 | 13% |
Unknown | 8 | 25% |